/

Società

H.

Non verificato

H. Lundbeck A/S

Di cosa scriviamo

AgricolturaEcologia/Salute ambientaleFitnessMedicina - VarieSalute

15 comunicati stampa

Guarda tutti i comunicati

10/06/2026

Salute

Fitness

Fiere

Eventi

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck to present new patient data on neuroendocrine and neuroimmunology programs at ENDO 2026

Fonte

H. Lundbeck A/S

Emittente

1.00

0

04/06/2026

Salute

Fitness

Fiere

Eventi

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

Fonte

H. Lundbeck A/S

Emittente

1.00

0

26/05/2026

Salute

Fitness

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine

Fonte

H. Lundbeck A/S

Emittente

1.00

0

18/05/2026

Salute

Fitness

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease

Fonte

H. Lundbeck A/S

Emittente

1.00

0

19/04/2026

Salute

Fitness

Cronaca Rosa / Gossip

Cronaca Bianca

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

Fonte

H. Lundbeck A/S

Emittente

1.00

0

13/04/2026

Salute

Fitness

Fiere

Eventi

Medicina - Varie

Scienza

Ecologia/Salute ambientale

Agricoltura

Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting

Fonte

H. Lundbeck A/S

Emittente

1.00

0

16/03/2026

Salute

Fitness

Cronaca Rosa / Gossip

Cronaca Bianca

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck advances Parkinson's research with new Phase 1b data at AD/PD™ 2026

Fonte

H. Lundbeck A/S

Emittente

1.00

0

10/03/2026

Salute

Fitness

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Lundbeck appoints Chief AI Officer

Fonte

H. Lundbeck A/S

Emittente

1.00

0

08/05/2025

Farmaceutica

Sanità

Lundbeck to share pipeline data and key insights into the progression of rare disease, Multiple System Atrophy, at International MSA Congress in Boston

Fonte

H. Lundbeck A/S

Emittente

1.00

0

06/05/2025

Farmaceutica

Information Technology

Telecomunicazioni

Sanità

Economia

Brevetti, marchi e copyright

Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer

Fonte

H. Lundbeck A/S

Emittente

1.00

0

Seguaci

0

Compatibilità

0